OUR STORY
Breakthroughs within reach
We didn’t just want to make a better supplement. We wanted to build something that didn’t exist, science that actually works with your biology to create lasting change.
Our proprietary biomimetic molecules are engineered to activate the body's natural peptide pathways, delivering real results in a daily, accessible tablet.
Bridging science and nature
We are pioneering the intersection of cutting-edge science and nature, creating the first supplements of their kind. Our formulas unlock the potential of natural ingredients to optimize human biology like never before.
The company
Evolv was co-founded by Dr. Cory Henderson, a molecular biologist who serves as Executive Chairman, Becca McCarthy, Co-Founder and CEO, and Dr. Kwang-Chul Kwon, Co-Founder and CTO. The company designs its peptides in-house and makes Evolv GLP-1 and Evolv Grow in the United States in a cGMP-compliant facility, with third-party testing and extensive quality standards. Founded in 2023, Evolv GLP-1 launched in August 2025.









